Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...

TURNING NOW TO THIS, A TRAGIC UPDATE TO A STORY WE’VE BEEN FOLLOWING SINCE HALLOWEEN. A MAN WHO POLICE SAY WAS THE VICTIM OF A HATE CRIME HAS DIED, AND THE SUSPECT ARRESTED FOR THE ATTACK IS NOW ...

Learn how to use advanced techniques like short-circuiting, parallel execution, virtual threads, and stream gatherers to maximize Java stream performance. My recent Java Stream API tutorial introduced ...

Rohit Prasad, the executive who has led Amazon’s artificial intelligence initiatives and overseen the creation of its homegrown Nova AI models, is leaving the company at the end of the year. In a memo ...

A dozen prior leaders of the U.S. Food and Drug Administration — appointed by Republicans and Democrats alike — issued a scathing denunciation of new FDA assertions casting doubt on vaccine safety.

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was chosen to lead the FDA’s drug division, according to four people familiar with ...

COVID-19 vaccinations probably contributed to the deaths of at least 10 children who died of heart inflammation, U.S. Food and Drug Administration chief medical and scientific officer Vinay Prasad ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

TIOBE Programming Index News – November 2025: C# Closes In on Java Your email has been sent The November 2025 TIOBE Index brings another twist below Python’s familiar lead. C solidifies its position ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Health secretary ...

The official, Dr. George Tidmarsh, has become embroiled in an ethical dispute and is now the target of a lawsuit over his actions involving certain drugs tied to a business associate. By Christina ...